Engineered Antibody Derivatives in Preclinical and Clinical Development.

MLA

Kellner, Christian, and Matthias Peipp. “Engineered Antibody Derivatives in Preclinical and Clinical Development.” Molecular & Cellular Mechanisms of Antibody Activity, Jan. 2013, pp. 251–84. EBSCOhost, https://doi.org/10.1007/978-1-4614-7107-3_10.

APA

Kellner, C., & Peipp, M. (2013). Engineered Antibody Derivatives in Preclinical and Clinical Development. Molecular & Cellular Mechanisms of Antibody Activity, 251–284. https://doi.org/10.1007/978-1-4614-7107-3_10

Chicago

Kellner, Christian, and Matthias Peipp. 2013. “Engineered Antibody Derivatives in Preclinical and Clinical Development.” Molecular & Cellular Mechanisms of Antibody Activity, January, 251–84. doi:10.1007/978-1-4614-7107-3_10.